Doxycycline for Sexually Transmitted Infection Prevention: Evolving Evidence and Implementation Perspectives
- PMID: 34117188
- PMCID: PMC8360665
- DOI: 10.1097/OLQ.0000000000001501
Doxycycline for Sexually Transmitted Infection Prevention: Evolving Evidence and Implementation Perspectives
Abstract
Editorial for Sexually Transmitted Diseases (STD20–495): Interest, concerns, and attitudes among men who have sex with men and healthcare providers toward prophylactic use of doxycycline against Chlamydia trachomatis infections and syphilis.
Conflict of interest statement
Conflict of Interest and Sources of Funding: None declared.
Comment on
-
Interest, Concerns, and Attitudes Among Men Who Have Sex With Men and Health Care Providers Toward Prophylactic Use of Doxycycline Against Chlamydia trachomatis Infections and Syphilis.Sex Transm Dis. 2021 Sep 1;48(9):615-619. doi: 10.1097/OLQ.0000000000001395. Sex Transm Dis. 2021. PMID: 33560092 Free PMC article.
References
-
- Molina JM Charreau I Chidiac C, et al. . Post-exposure prophylaxis with doxycycline to prevent sexually transmitted infections in men who have sex with men: an open-label randomised substudy of the ANRS IPERGAY trial. Lancet Infect Dis 2018; 18:308–317. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical